{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:16:40Z","timestamp":1786781800712,"version":"build-2736575974"},"reference-count":26,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Incident reporting systems allow for frontline employees to report errors and are a critical component of healthcare patient safety programs. Although incident reporting systems cannot quantify total errors, organizations can utilize incident reporting systems to help identify risks and trends to act upon. The objective of this article is to utilize incident reporting systems to evaluate trends in medication error reporting before and after implementation of a new electronic health record system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A five-month pre- and post-analysis was completed in a cancer hospital following electronic health record conversion by reviewing medication errors reported via the institution\u2019s voluntary incident reporting systems. Error reports included medication error category, date error was reported\/occurred, patient location at time of error, harm severity score, medication(s) involved, medication use system node error originated\/discovered in, medication source, narrative summary, and contributing factors. Data were analyzed using descriptive statistics within Office Excel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Oncology medication error reports submitted pre- and post-electronic health record were 68 vs. 57, respectively. During the pre- and post-electronic health record conversion, a majority of errors had a harm severity index of 0 or 1; 12 (18%) in pre-electronic health record and 3 (5%) in post-electronic health record were level 2, and one (1%) in pre-electronic health record vs. 0 in post-electronic health record were level 3. Reported medication errors originated most commonly during the prescribing, administration, and preparation\/dispensing phase and were primarily identified in the administration phase of the medication use process. The most frequently reported error category was \u2018wrong dose\u2019 followed by \u2018other\u2019 and \u2018overdose\u2019 in the pre-electronic health record phase and \u2018missing dose\/delayed delivery\u2019 and \u2018order incorrect\u2019 in the post-electronic health record phase. The most frequently reported medications included methotrexate, chemotherapy (unspecified), and cisplatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Analyzing data from incident reporting system reports allowed our institution to understand different trends of reporting in the cancer hospital following electronic health record adoption. Utilization of incident reporting systems must be combined with proactive risk identification approaches to enable systems-focused improvements to improve patient safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1078155219870590","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T13:22:07Z","timestamp":1567603327000},"page":"787-793","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of an electronic health record transition on chemotherapy error reporting"],"prefix":"10.1177","volume":"26","author":[{"given":"Elizabeth","family":"Hess","sequence":"first","affiliation":[{"name":"Medication Safety & Quality, UK HealthCare, Lexington, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon E","family":"Palmer","sequence":"additional","affiliation":[{"name":"UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stivers","sequence":"additional","affiliation":[{"name":"Medication Use & Safety, Emory University Hospital Midtown, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2607-7060","authenticated-orcid":false,"given":"Lindsey B","family":"Amerine","sequence":"additional","affiliation":[{"name":"UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA"},{"name":"Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"key":"bibr1-1078155219870590","doi-asserted-by":"crossref","unstructured":"ASHP statement on reporting medical errors.\n                      Am J Health Syst Pharm\n                      2000; 57:1531\u20131532.","DOI":"10.1093\/ajhp\/57.16.1531"},{"key":"bibr2-1078155219870590","unstructured":"Donaldson MS, Corrigan JM and Kohn LT (eds).\n                      To err is human: building a safer health system\n                      . Vol. 6. Washington: National Academies Press, 2000."},{"key":"bibr3-1078155219870590","unstructured":"Joint Commission. Leadership standard. 03.01.01. In:\n                      Comprehensive accreditation manual for hospitals\n                      . Oakbrook Terrace: Joint Commission, 2018, LD-3."},{"key":"bibr4-1078155219870590","unstructured":"DNV GL Healthcare. NIAHO\u00ae Accreditation Requirements Interpretive Guidelines & Surveyor Guidance \u2013 Revision 16. Milford: DNV GL Healthcare USA, 2016."},{"key":"bibr5-1078155219870590","volume-title":"Hospital incident reporting systems do not capture most patient harm","author":"Levinson DR","year":"2012"},{"key":"bibr6-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2004.012559"},{"key":"bibr7-1078155219870590","first-page":"154","volume":"2","author":"Pharm JC","year":"2013","journal-title":"J Public Health Res"},{"key":"bibr8-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/62.4.416"},{"key":"bibr9-1078155219870590","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060001"},{"key":"bibr10-1078155219870590","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050379"},{"key":"bibr11-1078155219870590","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060617"},{"key":"bibr12-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1016\/j.cali.2012.01.010"},{"key":"bibr13-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2009.002444"},{"key":"bibr14-1078155219870590","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp170228"},{"key":"bibr15-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.10.1197"},{"key":"bibr16-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M2042"},{"key":"bibr17-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M3050"},{"key":"bibr18-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M2419"},{"key":"bibr19-1078155219870590","first-page":"113","volume":"9","author":"Sparnon E","year":"2012","journal-title":"Pa Patient Saf Advis"},{"key":"bibr20-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M2338"},{"key":"bibr21-1078155219870590","doi-asserted-by":"publisher","DOI":"10.2146\/sp150001"},{"key":"bibr22-1078155219870590","unstructured":"American Hospital Association Health Research and Educational Trust and the Institute for Safe Medication Practices. Pathways for medication safety: looking collectively at risk. Section 2.3, www.ismp.org\/tools\/PathwaySection2.pdf (accessed 14 January 2018)."},{"key":"bibr23-1078155219870590","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060617"},{"key":"bibr24-1078155219870590","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7273"},{"key":"bibr25-1078155219870590","unstructured":"Frankel A. Patient safety leadership walkrounds. Institute for Healthcare Improvement, 2004, www.ihi.org\/resources\/Pages\/Tools\/PatientSafetyLeadershipWalkRounds.aspx (accessed 9 August 2019)."},{"key":"bibr26-1078155219870590","first-page":"1","volume":"23","author":"ISMP","year":"2017","journal-title":"ISMP Med Saf Alert"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155219870590","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155219870590","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155219870590","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:21:50Z","timestamp":1777688510000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155219870590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1177\/1078155219870590"],"URL":"https:\/\/doi.org\/10.1177\/1078155219870590","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,4]]}}}